-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, WCIGh9rJHcQ2GnW0PPMoICbQ8pPIVlPkUtFn1wqtd3wA/ErHSGibGHvlPde6hvqC XJeMJXN1WgiaLvyoyjzupQ== 0001019687-03-001841.txt : 20030902 0001019687-03-001841.hdr.sgml : 20030901 20030902151017 ACCESSION NUMBER: 0001019687-03-001841 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20030902 ITEM INFORMATION: Other events ITEM INFORMATION: Financial statements and exhibits FILED AS OF DATE: 20030902 FILER: COMPANY DATA: COMPANY CONFORMED NAME: SIMULATIONS PLUS INC CENTRAL INDEX KEY: 0001023459 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMPUTER INTEGRATED SYSTEMS DESIGN [7373] IRS NUMBER: 954595609 FISCAL YEAR END: 0831 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 333-05600-LA FILM NUMBER: 03876214 BUSINESS ADDRESS: STREET 1: 1220 W. AVENUE J STREET 2: * CITY: LANCASTER STATE: CA ZIP: 93534-2902 BUSINESS PHONE: 661-723-7723 MAIL ADDRESS: STREET 1: 1220 W. AVENUE J STREET 2: * CITY: LANCASTER STATE: CA ZIP: 93534-2902 8-K 1 simulations_8k-090203.txt UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 September 2, 2003 ----------------- (Date of the earliest event reported) Simulations Plus, Inc. ---------------------- (Exact name of registrant as specified in its charter) California 000-21665 95-4595609 ---------- ------------ ---------- (State or other jurisdiction (Commission (I.R.S. Employer of incorporation) File Number) Identification No.) 1220 W. Avenue J, Lancaster, California 93534 --------------------------------------------- (Address of principal executive offices) (Zip Code) 661-723-7723 ------------- Registrant's telephone number, including area code ITEM 5: OTHER EVENTS. On August 29, 2003, Simulations Plus, Inc. (the "Company") issued a press release announcing preliminary revenue for the fiscal quarter and fiscal year ending August 31, 2003. A copy of the press release hereto is attached as Exhibit 99.1. This report on Form 8-K (the "Report"), including the disclosures set forth herein, contains certain forward-looking statements that involve substantial risks and uncertainties. When used herein, the terms "anticipates," "expects," "estimates," "believes" and similar expressions, as they relate to us or our management, are intended to identify such forward-looking statements. Forward-looking statements in this Report or hereafter, including in other publicly available documents filed with the Securities and Exchange Commission (the "Commission"), reports to the stockholders of Simulations Plus, Inc., a California corporation (the "Company" or "us," "our" or "we") and other publicly available statements issued or released by us involve known and unknown risks, uncertainties and other factors which could cause our actual results, performance (financial or operating) or achievements to differ from the future results, performance (financial or operating) or achievements expressed or implied by such forward-looking statements. Such future results are based upon management's best estimates based upon current conditions and the most recent results of operations. These risks include, but are not limited to, the risks set forth herein and in such other documents filed with the Commission, each of which could adversely affect our business and the accuracy of the forward-looking statements contained herein. Our actual results, performance or achievements may differ materially from those expressed or implied by such forward-looking statements. ITEM 7: FINANCIAL STATEMENTS, PRO FORMA FINANCIAL INFORMATION AND EXHIBITS. ------------------------------------------------------------------ (c) Exhibits 99.1 Press Release dated August 29, 2003. SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized. SIMULATIONS PLUS, INC. Dated: September 2, 2003 By: /s/ Walter S. Woltosz ------------------------------------- Walter S. Woltosz Chief Executive Officer and President EX-99.1 3 simulations_8kex99-1.txt EXHIBIT 99.1 SIMULATIONS PLUS ANNOUNCES RECORD REVENUES FOR FOURTH QUARTER AND FISCAL YEAR COMPANY EXPECTS TO APPLY FOR NASDAQ SMALLCAP LISTING LANCASTER, CA, AUGUST 29, 2003. Simulations Plus, Inc. (OTCBB: SIMU.OB), the leading provider of ADME absorption simulation and neural net structure-to-property prediction software for pharmaceutical discovery and development, today reported preliminary revenue for the fiscal fourth quarter and fiscal year ended August 31, 2003. Ronald Creeley, vice president of Marketing and Sales for Simulations Plus, said, "I'm pleased and excited to report that a major pharmaceutical company recently signed a multi-year subscription to a modified ADME Partners program. ADME Partners is a software licensing program developed by Simulations Plus to provide clients cost-effective, multiple-location site licenses with unlimited access to all Simulations Plus software programs. The result of this sale along with our other sales for the fourth quarter is that fourth quarter pharmaceutical software and services revenues will approach $1.5 million, more than doubling the previous high quarter record set last quarter. The modified subscription does not include the usual consultation and training, but covers only software licenses." Momoko Beran, chief financial officer of Simulations Plus, said, "Our preliminary numbers show pharmaceutical software and services revenues increased 148.7% to $1,480,000 for the fourth quarter compared to $595,000 for the fourth fiscal quarter of 2002, and for the fiscal year increased 55.8% to $3,183,000, compared to $2,043,000 for fiscal 2002. Total revenues including our Words+ subsidiary increased 72.6% to a new record $2,089,000 for the fourth quarter compared to $1,210,000 for the fourth fiscal quarter of 2002. Fourth quarter revenues for our Words+ subsidiary decreased 1.0% over last year's fourth quarter. For the fiscal year, Words+ revenues decreased 1.5%. Total revenues for the fiscal year, including the Words+ subsidiary, increased 24.8% to $5,547,000, compared to $4,444,000 for fiscal 2002." Ms. Beran continued, "Based on the information we have right now, we expect fourth quarter fully diluted earnings to be between $0.17 and $0.21 per share, and for the fiscal year, between $0.28 and $0.32 per share." Walt Woltosz, chairman and chief executive officer of Simulations Plus, commented, "It's difficult to contain our excitement about this year's performance. We've maintained steady growth, growing profitability, and made significant expansions to our product line this year. It is our current understanding that our earnings for this fiscal year will enable us to apply for listing on Nasdaq SmallCap, provided that the stock price exceeds $4.00. This will probably have to wait until our 10K is filed in November." Woltosz continued, "Simulations Plus enjoys a reputation for excellence in science and software. Our consulting expertise and software products have served many of the top scientists in some of the largest research organizations in the world. However, we will not rest on our laurels. We intend to leverage our technical and financial strengths to fuel further growth by identifying and fulfilling needs in pharmaceutical research as we have done with GastroPlus(TM), QMPRPlus(TM), and QMPRchitect(TM)." ABOUT SIMULATIONS PLUS, INC. Simulations Plus, Inc., is a premier developer of groundbreaking drug discovery and development simulation software, which is licensed to and used in the conduct of drug research by major pharmaceutical and biotechnology companies worldwide. The Company has two other businesses, Words+, Inc. and FutureLab(TM), which are based on its proprietary software technologies. Simulations Plus, Inc., is headquartered in Southern California and trades on the OTCBB under the symbol "SIMU.OB." For more information, visit our Web site at www.simulations-plus.com. - ------------------------- Safe Harbor Statement Under the Private Securities Litigation Act 1995 - With the exception of historical information, the matters discussed in this press release are forward-looking statements that involve a number of risks and uncertainties. The actual future results of the Company could differ significantly from those statements. Factors that could cause or contribute to such differences include, but are not limited to: the ability of the Company to book revenues and earnings as it expects for the current quarter, the ability of the Company to maintain its competitive advantage, the general economics of the pharmaceutical industry, the ability of the Company to attract and maintain sufficient scientific and technical staff to sustain its R&D and customer support functions, and a sustainable market. Further information on the Company's risk factors is contained in the Company's quarterly and annual reports as filed with the Securities and Exchange Commission. ### -----END PRIVACY-ENHANCED MESSAGE-----